Skip to main content

Advertisement

SpringerLink
Log in

Evaluation and Treatment Urosepsis

  • Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Urosepsis is a severe, and sometimes fatal, infection starting in the urinary tract leading to systemic infection and complicated by patient immune and inflammatory responses. The practicing urologist should recognize the multiple risk factors that may increase the risk of urosepsis and follow early goal-directed therapy. In many cases, the urologist is involved to alleviate the source of infection and in a team-based approach, can alter patient outcome. Urosepsis after common urological procedures is often preventable with the use of antimicrobial prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Levy M, Artigas A, Phillips G, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–24. doi:10.1016/s1473-3099(12)70239-6.

    Article  PubMed  Google Scholar 

  2. Schroder J. Gender differences in human sepsis. Arch Surg. 1998;133(11):1200–5.

    Article  CAS  PubMed  Google Scholar 

  3. Mayr F. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303(24):2495. doi:10.1001/jama.2010.851.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Wein A, Kavoussi L, Campbell M, Walsh P. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 258.

    Google Scholar 

  5. Kalra O. Approach to a patient with urosepsis. J Global Infect Dis. 2009;1(1):57. doi:10.4103/0974-777x.52984.

    Article  Google Scholar 

  6. Lee J, Lee Y, Cho J. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother. 2012;18(1):130–3. doi:10.1007/s10156-011-0289-z.

    Article  PubMed  Google Scholar 

  7. Flaherty S, Weber R, Chase M, et al. Septic shock and adequacy of early empiric antibiotics in the emergency department. J Emerg Med. 2014;47(5):601–7. doi:10.1016/j.jemermed.2014.06.037.

    Article  PubMed  Google Scholar 

  8. Levy M, Fink M, Marshall J, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–6. doi:10.1097/01.ccm.0000050454.01978.3b.

    Article  PubMed  Google Scholar 

  9. Wagenlehner F, Lichtenstern C, Rolfes C, et al. Diagnosis and management for urosepsis. Int J Urol. 2013. doi:10.1111/iju.12200. This article summarized the pathophysiology and management of sepsis from the urological perspective.

    PubMed  Google Scholar 

  10. Wein A, Kavoussi L, Campbell M, Walsh P. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 313.

    Google Scholar 

  11. Angus D, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(21):2062–3. doi:10.1056/nejmc1312359.

    Article  Google Scholar 

  12. Dellinger R, Levy M, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. doi:10.1007/s00134-012-2769-8. The campaign in this article aimed at reducing mortality by 25 % from sepsis in the next few years.

    Article  CAS  PubMed  Google Scholar 

  13. Kumar A, Roberts D, Wood K, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*. Crit Care Med. 2006;34(6):1589–96. doi:10.1097/01.ccm.0000217961.75225.e9.

    Article  PubMed  Google Scholar 

  14. Wagenlehner F, Weidner W, Naber K. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. Clin Pharmacokinet. 2007;46(4):291–305. doi:10.2165/00003088-200746040-00003.

    Article  CAS  PubMed  Google Scholar 

  15. Sorensen S, Schonheyder H, Nielsen H. The role of imaging of the urinary tract in patients with urosepsis. Int J Infect Dis. 2013;17(5):e299–303. doi:10.1016/j.ijid.2012.11.032.

    Article  PubMed  Google Scholar 

  16. Wang I. The use of ultrasonography in evaluating adults with febrile urinary tract infection. Ren Fail. 2003;25(6):981–7.

    Article  PubMed  Google Scholar 

  17. Ifergan J, Pommier R, Brion M, Glas L, Rocher L, Bellin M. Imaging in upper urinary tract infections. Diagn Int Imaging. 2012;93(6):509–19. doi:10.1016/j.diii.2012.03.010.

    Article  CAS  Google Scholar 

  18. Ramsey S, Robertson A, Ablett M, Meddings R, Hollins G, Little B. Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol. 2010;24(2):185–9. doi:10.1089/end.2009.0361.

    Article  PubMed  Google Scholar 

  19. Berger I, Wildhofen S, Lee A, et al. Emergency nephrectomy due to severe urosepsis: a retrospective, multicentre analysis of 65 cases. BJU Int. 2009;104(3):386–90. doi:10.1111/j.1464-410x.2009.08414.x.

    Article  PubMed  Google Scholar 

  20. Wolf J, Bennett C, Dmochowski R, Hollenbeck B, Pearle M, Schaeffer A. Best practice policy statement on UROLOGIC SURGERY ANTIMICROBIAL PROPHYLAXIS. 2007. Available at: https://www.auanet.org/education/guidelines/antimicrobial-prophylaxis.cfm#18. Accessed 1 June 2015.

  21. Purves J, McIntyre M. Nosocomial urinary tract infections. AUA Updat Ser. 2010;29(17):162–7.

    Google Scholar 

  22. Carmignani L, Picozzi S, Spinelli M, et al. Bacterial sepsis following prostatic biopsy. Int Urol Nephrol. 2012;44(4):1055–63. doi:10.1007/s11255-012-0145-9.

    Article  PubMed  Google Scholar 

  23. Korets R, Graversen J, Kates M, Mues A, Gupta M. Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol. 2011;186(5):1899–903. doi:10.1016/j.juro.2011.06.064.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Judy Farias, Mohamed Kamel, and Ehab Eltahawy declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. University of Arkansas for Medical Science, 4301 W Markham St #540, Little Rock, AR, 72205, USA

    Judy Farias, Mohamed Kamel & Ehab Eltahawy

Authors
  1. Judy Farias
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed Kamel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ehab Eltahawy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ehab Eltahawy.

Additional information

This article is part of the Topical Collection on Inflammatory/Infectious Bladder Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farias, J., Kamel, M. & Eltahawy, E. Evaluation and Treatment Urosepsis. Curr Bladder Dysfunct Rep 10, 193–197 (2015). https://doi.org/10.1007/s11884-015-0301-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-015-0301-z

Keywords

Search

Navigation